N Pedersen
Overview
Explore the profile of N Pedersen including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
71
Citations
1737
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Faurschou I, Ankersen J, Pedersen N, Sorensen M, Friis M, Pedersen A, et al.
Colorectal Dis
. 2025 Jan;
27(2):e70003.
PMID: 39871414
Aim: Pilonidal sinus disease (PSD) is a common condition particularly affecting young men. Females affected by the condition account for about 20% of patients and are rarely mentioned, much less...
2.
De Lima-Karagiannis A, Juillerat P, Sebastian S, Pedersen N, Bar-Gil Shitrit A, van der Woude C
J Crohns Colitis
. 2020 Oct;
14(14 Suppl 3):S807-S814.
PMID: 33085970
Podcast: This article has an associated podcast which can be accessed at https://academic.oup.com/ecco-jcc/pages/podcast.
3.
Bank S, Andersen P, Burisch J, Pedersen N, Roug S, Galsgaard J, et al.
Pharmacogenomics J
. 2017 Feb;
18(1):87-97.
PMID: 28139755
Anti-tumour necrosis factor-α (TNF-α) is used for treatment of severe cases of inflammatory bowel diseases (IBD), including Crohn's disease (CD) and ulcerative colitis (UC). However, one-third of the patients do...
4.
Raaschou-Nielsen O, Beelen R, Wang M, Hoek G, Andersen Z, Hoffmann B, et al.
Environ Int
. 2015 Dec;
87:66-73.
PMID: 26641521
Background: Particulate matter (PM) air pollution is a human lung carcinogen; however, the components responsible have not been identified. We assessed the associations between PM components and lung cancer incidence....
5.
Vegh Z, Burisch J, Pedersen N, Kaimakliotis I, Duricova D, Bortlik M, et al.
J Crohns Colitis
. 2015 Jun;
9(9):747-53.
PMID: 26055976
Background And Aims: The ECCO-EpiCom study investigates the differences in the incidence and therapeutic management of inflammatory bowel diseases [IBD] between Eastern and Western Europe. The aim of this study...
6.
van der Woude C, Ardizzone S, Bengtson M, Fiorino G, Fraser G, Katsanos K, et al.
J Crohns Colitis
. 2015 Jan;
9(2):107-24.
PMID: 25602023
Trying to conceive and being pregnant is an emotional period for those involved. In the majority of patients suffering from inflammatory bowel disease, maintenance therapy is required during pregnancy to...
7.
Vegh Z, Burisch J, Pedersen N, Kaimakliotis I, Duricova D, Bortlik M, et al.
J Crohns Colitis
. 2014 Jul;
8(11):1506-15.
PMID: 24998983
Background And Aims: The aim of the present study was to validate the IBD (inflammatory bowel diseases) incidence reported in the 2010 ECCO-EpiCom (European Crohn's and Colitis Organization-Epidemiological Committee) inception...
8.
Bank S, Andersen P, Burisch J, Pedersen N, Roug S, Galsgaard J, et al.
Pharmacogenomics J
. 2014 Apr;
14(6):526-34.
PMID: 24776844
Antitumor necrosis factor-α (TNF-α) is used for treatment of severe cases of inflammatory bowel diseases (IBD), including Crohn's disease (CD) and ulcerative colitis (UC). However, one-third of the patients do...
9.
Burisch J, Weimers P, Pedersen N, Cukovic-Cavka S, Vucelic B, Kaimakliotis I, et al.
J Crohns Colitis
. 2014 Feb;
8(9):1030-42.
PMID: 24560877
Background & Aims: Health-related quality of life (HRQoL) is impaired in patients with Inflammatory Bowel Disease (IBD). The aim was prospectively to assess and validate the pattern of HRQoL in...
10.
Burisch J, Vegh Z, Pedersen N, Cukovic-Cavka S, Turk N, Kaimakliotis I, et al.
J Crohns Colitis
. 2014 Jan;
8(8):811-8.
PMID: 24439390
Background And Aims: The EpiCom study and inception cohort was initiated in 2010 in 31 centers from 14 Western and 8 Eastern European countries, covering a 10.1million person background population....